International Journal of Research in Pharmacy and Allied Science

ISSN: 2583-6544   |  Issues per year: Monthly  |   Indexed In: Google Scholar, CORE, ScienceOpen, Researchgate

ISSN:2583-6544

Abstract View

A Review on Diabetes Mellitus: Type1 & Type2

Author(s): Araman Alam1, Roshan Kumar2, Avantika kumari3, Bharti sahu4

Email(s): 1aramanalam167@gmail.com

Address:

    Maya college of pharmacy, Dehradun.

Published In:   Volume - 4,      Issue - 4,     Year - 2025

DOI: https://doi.org/10.71431/IJRPAS.2025.4401  

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Diabetes mellitus is a chronic disease. which identified hyperglycemia caused by insulin and action and secretion.the two general categories into which fall are type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) T1DM is an autoimmune disease that usually first appears in childhood or adolescence and causes the death of pancreatic β-cells and consequent insulin deficiency. On the other hand, type 2 diabetes, which is more common, is primarily associated with insulin resistance and relative insulin deficiency, often associated with genetic, environmental and lifestyle influences. This article compares the origins, pathophysiology, clinical features, diagnostic standards and therapeutic approaches of type 1 and type 2 diabetes. It also looks at new developments in treatment and emphasises how important lifestyle changes, early identification and patient education are to manage the disease course and prevent complications. Effective diagnosis, treatment, and investigation of a possible cure depend on understanding the differences and overlap between type 1 and type 2 diabetes.

Keywords:

Cite this article:
Araman Alam, Roshan Kumar, Avantika kumari, Bharti sahu. A Review on Diabetes Mellitus: Type1 & Type2. IJRPAS, April 2025; 4 (4): 01-11. https://doi.org/10.71431/IJRPAS.2025.4401DOI: https://doi.org/https://doi.org/10.71431/IJRPAS.2025.4401


1.             M. Upendra Rao, M. Sreenivasulu, B. Chengaiah, K. Jaganmohan Reddy, C. Madhusudhana Chetty. Herbal Medicines for Diabetes Mellitus: A Review, International Journal of PharmTech Research, 2010; Vol.2, No.3, pp 1883-1892.

2.             Shikha Srivastava, Vijay Kumar Lal, Kamlesh Kumar Pant. Polyherbal formulations based on Indian medicinal plants as antidiabetic Phytopharmacology. 2012; 2(1) 1-15.

3.             Rodbard HW, Blonde L, Braithwaite SS, Brett EM, Cobin RH, Handelsman Y, Hellman R, Jellinger PS, Jovanovic LG, Levy P, Mechanick JI, Zangeneh F; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13 Suppl 1:1-68.

4.             Azizi F, Guoya MM, Vazirian P, Dolatshati P, Habbibian S. Screening for type 2 diabetes in the Iranian national programme: a preliminary report. East Mediterr Health J 2003;9(5-6):1122-7.

5.             Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.

6.             http://www.annals.org/site/misc/about.xhtml

7.             http://www.archive.org/stream/ondiabetesmelli00kleegoog/ondiabetesmelli00kleegoog_djvu.t xt

8.             Ross and Wilson. Anatomy and Pathophysiology in Health and Illness, Churchill Livingstone Elsevier, 11th edition, 2010, 227-229.

9.             Alemu S, Dessie A, Seid E. Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutritionrelated diabetes, Diabetologia. 2009; 52:1842-1845

10.         Wild S, Roglic G, Green A, Sicree R, King. Global prevalence of diabetes: Estimates for the year 2000and projections for 2030, Diabetes Care. 2004; 27:1047-53.

11.         Gupta OP, Joshi MH, Daves SK. Prevalence of Diabetes in India, Adv Metab Disord. 1978; 9:147-65.

12.         Alemu S, Dessie A, Seid E. Insulin-requiring diabetes in rural Ethiopia: should we reopen the case for malnutritionrelated diabetes, Diabetologia. 2009; 52:1842-1845

13.         Gupta OP, Joshi MH, Daves SK. Prevalence of Diabetes in India, Adv Metab Disord. 1978; 9:147-65.

14.         Bordoloi R, Dutta KN. A Review on Herbs Used in the Treatment of Diabetes mellitus.Journal of Pharmaceutical,Chemical and Biological. Sciences;2014(2):86–92.

15.         Malvi R, Jain S, Khatri S, Patel A, Mishra S. A Review on Antidiabetic Medicinal Plants and Marketed Herbal For mulations. International Journal of Pharmaceutical & Biological Archives;2011(2):1344–1355.

16.          Rahimi M. A Review: Anti Diabetic medicinal plants used for diabetes mellitus. Bulletin of environmental, pharmacology and life. sciences;2015(4):163–180.

17.          Mishra R, Shuaib M, Shravan M, S P. A review on herbal antidiabetic drugs. Journal of Applied Pharmaceutical Science2011;1(6):235–237.

18.         Rahimi M. A Review: Anti Diabetic medicinal plants used for diabetes mellitus. Bulletin of environmental, pharma- cology and life. sciences;2015(4):163–180.

19.         Dwivedi CP, Daspaul S. Antidiabetic herbal drugs and polyherbal formulation used for diabetes: A review. The journal of phytopharmacology;2013(2):44–51.

20.         Addae M.I., Achenbach H.: Phytochemistry 24, 1817 (1985).

21.         Sokeng S.D., Rokeya B., Mostafa M., et al.: Afr. J. Tradit. Complement. Altern. Med. 2, 94 (2005).

22.         Punitha I.S.R., Rajendran K., Shirwaikar A., et al.: Alternat. Med. 2, 375 (2005).

23.         Pearson, M.J.; Unger, R.H.; Holland, W.L. Clinical Trials, Triumphs, and Tribulations of Glucagon Receptor Antagonists. Diabetes Care 2016, 39, 1075–1077

24.         Scheen, A.J.; Paquot, N.; Lefèbvre, P.J. Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes. Expert. Opin. Investig. Drugs 2017, 26, 1373–1389.

25.         Chen, Y.-S.; Weng, S.-J.; Chang, S.-H.; Li, R.-Y.; Shane, G.-T.; Hsu, J.-P.; Yeh, S.-W.; Chang, A.-C.; Lee, M.-J.E. Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models. PLoS ONE 2021, 16, e0255405.

26.         Klec, C.; Ziomek, G.; Pichler, M.; Malli, R.; Graier, W.F. Calcium Signaling in ß-cell Physiology and Pathology: A Revisit. Int. J. Mol. Sci. 2019, 20, 6110

27.         Andersson, D.E.; Röjdmark, S. Blood glucose lowering effect of verapamil in fasted man. Horm. Metab. Res. 1984, 16 (Suppl. S1), 160–163

28.         Fadda, G.Z.; Hajjar, S.M.; Zhou, X.J.; Massry, S.G. Verapamil corrects abnormal metabolism of pancreatic islets and insulin secretion in phosphate depletion. Endocrinology 1992, 130, 193–202.

29.         Jahan, I.; Corbin, K.L.; Bogart, A.M.; Whitticar, N.B.; Waters, C.D.; Schildmeyer, C.; Vann, N.W.; West, H.L.; Law, N.C.; Wiseman, J.S.; et al. Reducing Glucokinase Activity Restores Endogenous Pulsatility and Enhances Insulin Secretion in Islets From db/db Mice. Endocrinology 2018, 159, 3747–3760.

30.         Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J (2014) 18(3):88–93. doi:10.7812/TPP/14-002

31.         (2016). Available from: http://care.diabetesjournals.org/content/39/ Supplement_1

32.         Riser Taylor S, Harris KB. The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2diabetes mellitus. Pharmacotherapy (2013) 33(9):984–99. doi:10.1002/phar.1303

33.         . Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes (2002) 51(3):5368–76. doi:10.2337/diabetes.51.2007.S368

Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags


Quick Links


Latest Issues

Popular Articles